CAS 72444-63-4
:Lodiperone
Description:
Lodiperone is an atypical antipsychotic medication primarily used in the treatment of schizophrenia. It functions as a dopamine D2 receptor antagonist, which helps to alleviate symptoms associated with this mental health disorder. In addition to its action on dopamine receptors, Lodiperone also interacts with serotonin receptors, particularly the 5-HT2A subtype, contributing to its therapeutic effects and potentially reducing side effects commonly associated with traditional antipsychotics. The chemical structure of Lodiperone includes a piperazine moiety, which is characteristic of many antipsychotic agents. Its pharmacokinetic profile suggests that it has a favorable absorption and distribution in the body, with a moderate half-life that allows for once-daily dosing in clinical settings. As with other antipsychotics, monitoring for side effects such as weight gain, metabolic changes, and extrapyramidal symptoms is essential during treatment. Overall, Lodiperone represents a valuable option in the pharmacological management of schizophrenia, offering a balance between efficacy and tolerability.
Formula:C21H20Cl2FN3O2
InChI:InChI=1/C21H20Cl2FN3O2/c22-15-11-16(23)13-18(12-15)27-9-7-26(8-10-27)6-5-19-20(25-21(28)29-19)14-1-3-17(24)4-2-14/h1-4,11-13H,5-10H2,(H,25,28)
SMILES:c1cc(ccc1c1c(CCN2CCN(CC2)c2cc(cc(c2)Cl)Cl)oc(n1)O)F
Synonyms:- Lodiperone [INN]
- 5-(2-(4-(3,5-Dichlorophenyl)-1-piperazinyl)ethyl)-4-(p-fluorophenyl)-4-oxazolin-2-one
- 5-(2-(4-(3,5-Dichlorphenyl)-1-piperazinyl)ethyl)-4-(4-fluorphenyl)-2(3H)-oxazolon
- 5-(2-(4-(3,5-Dichlorphenyl)-1-piperazinyl)ethyl)-4-(4-fluorphenyl)-4-oxazolin-2-on
- Lodiperon
- Unii-T8593Bt7B4
- 5-{2-[4-(3,5-dichlorophenyl)piperazin-1-yl]ethyl}-4-(4-fluorophenyl)-1,3-oxazol-2(3H)-one
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 2 products.
Lodiperone
CAS:<p>Lodiperone is a bioactive chemical.</p>Formula:C21H20Cl2FN3O2Color and Shape:SolidMolecular weight:436.31
